Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. CRISPR Therapeutics AG’s current trading price is -56.13% away from its 52-week high, while its distance from the 52-week low is 9.43%. The stock’s price range during this period has varied between $36.52 and $91.10. The company, active in the Healthcare sector, saw a trading volume of around 1.07 million for the day, considerably lower average daily volume of 1.92 million observed over the last three months.
CRISPR Therapeutics AG had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $91.10 on 02/22/24, while the lowest price during the same period was $36.52 on 01/13/25.
How Financial Performance Impacts Market Capitalization
CRISPR Therapeutics AG (CRSP) has experienced a quarterly decline of -20.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.41B and boasts a workforce of 407 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 45.77, with a change in price of -8.95. Similarly, CRISPR Therapeutics AG recorded 1,638,975 in trading volume during the last 100 days, posting a change of -18.30%.
How CRSP’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRSP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
CRSP Stock Stochastic Average
As of today, the raw stochastic average of CRISPR Therapeutics AG over the last 50 days is at 18.26%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 37.46%. Further, the company’s Stochastic %K and %D values for the last 20 days were 47.77% and 48.25%, respectively.
CRSP Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 1.54%. However, over the past six months, we’ve seen a stronger performance of -15.45%. The price of CRSP leaped by -4.66% over the last 30 days. And in the last five days, it has fallen by -3.91%.
